This study, published in the Journal of American Medical Association, evaluates the projected health and economic impact of pneumococcal conjugate vaccination of healthy US infants and young children through a cost-effectiveness analysis based on data from the Northern California Kaiser Permanente randomized trial and other published and unpublished sources. ABSTRACT ONLY. (Learn how users in developing countries can gain free access to journal articles.)

Author(s): Lieu TA, Ray GT, Black SB, et al.

Published: 2000

Resource types: Peer-reviewed journal

Diseases: Pneumococcus

Topics: Disease/vaccine specific information

Regions: North America and Europe